Digestive Diseases أخبار مميزة April 09, 2021 Inflammatory bowel disease (IBD) research at Mayo Clinic Mayo Clinic continues to explore frontiers in research, diagnostics, drug trials and treatment algorithms to advance IBD treatment and offer options to patients that change the course of their disease. April 17, 2021 Encouraging innovation in gastroenterology and endoscopy Mayo Clinic gastroenterologist Elizabeth Rajan, M.D., answers questions about the skills and processes that guide physician-investigators working on device and technology innovation. April 17, 2021 Young-onset esophageal adenocarcinoma: Results from a population-based study Mayo Clinic research examining the incidence, stage distribution and survival outcomes associated with esophageal adenocarcinoma (EAC) in a large population-based study yields some surprising results about young-onset EAC. Feb. 05, 2021 How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. Prospective disease evaluation, improved control of confounding factors, and obesity measures that reflect visceral adipose tissue are needed to understand obesity's role in the pathogenesis and management of inflammatory bowel disease (IBD). Nonalcoholic steatohepatitis (NASH) research at Mayo Clinic Mayo Clinic researchers ask and answer fundamental questions about nonalcoholic steatohepatitis (NASH). Exploring colorectal cancer clinical trials Mayo Clinic colorectal cancer experts talk about the latest in colorectal cancer clinical trials. Endoscopic ultrasound-guided angiotherapy Michael J. Levy, M.D., a gastroenterologist at Mayo Clinic’s campus in Rochester, Minnesota, discusses endoscopic ultrasound (EUS)-guided angiotherapy for the treatment of gastrointestinal bleeding. Calculators These models are to be used by medical professionals. Publications PRINT EDITION See the latest edition plus past issues E-NEWSLETTER EDITION See the latest edition plus past issues 1 Assessing the prevalence of Barrett's esophagus in patients with scleroderma 2 Assessing the performance of methylated DNA markers in blood for detection of pancreatic ductal adenocarcinoma 3 Using a phenotype-guided approach for the treatment of obesity 4 Understanding and managing chronic abdominal bloating and distension 5 Convolutional neural network trained to distinguish autoimmune pancreatitis from pancreatic ductal adenocarcinoma and benign pancreas conditions تغريدات من MayoClinicGIHep المتخصصون في المجالات الطبية Digestive Diseases